Advertisement

My story: my hepatitis C journey as a Black American

Updated on October 23, 2024

Pat, a hepatitis c survivor, leads by example as a health advocate. In this video, Pat shares her thoughts on disparity within the healthcare system.

Featured Content

video

Patient perspectives: understanding healthcare equity as a provider, patient, or person of color

From representation reflected in specialties of medical professionals, to balance within clinical trials, health equity is an ongoing evolution.
article

Why hepatitis C is called a "quiet killer"

Most people with hepatitis C have no symptoms until the disease has caused serious liver damage. Here’s what you need to know about hep C diagnosis.
video

How blood transfusions for sickle cell may have impacted hepatitis C rates among Black Americans

In the past, donated blood was not screened for hepatitis C, and this could have negatively impacted transfusions for sickle cell anemia.
video

The importance of diversity in clinical trials for hepatitis C

Diversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.